Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Michael Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104974055B reveals high stereoselectivity synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN1626501A details a high-efficiency ruthenium-catalyzed asymmetric Michael addition for producing optically active nitro and cyano compounds, offering significant cost reduction in API manufacturing.
Patent CN113214112A reveals a mild, base-catalyzed route for beta-amino acrylate substituted acetonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel preparation method for atracurium besilate intermediates via Michael addition and transesterification, offering high purity and cost-effective manufacturing solutions.
Patent CN109851594B details a cost-effective 5-step synthesis of 3-aminomethyl tetrahydrofuran from furan, offering significant supply chain advantages for dinotefuran production.
Patent CN107311911B reveals a novel chemical route for Niraparib intermediates, replacing costly enzymatic methods with scalable asymmetric synthesis for reliable supply.
Patent CN103755667A reveals a novel organocatalytic route for chiral tetrahydrofurans, offering superior enantioselectivity and scalable manufacturing for global API supply chains.
Patent CN115073291A reveals a continuous flow process for diethyl acetonyl succinate, offering significant cost reduction in plant growth regulator manufacturing and enhanced supply reliability.
Patent CN114516796A reveals a cost-effective Michael addition route for 5-oxohexanoate using dual-function catalysts, offering high selectivity and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN119735538B details high-purity Brivaracetam production. This route offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturers.
Novel Lewis acid catalyzed route offers mild conditions and high purity for complex heterocyclic pharmaceutical intermediates.
Patent CN104860911B reveals a metal-free synthesis for chiral 3,4-dihydrocoumarin derivatives. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN107188874A reveals efficient Cu-catalyzed Michael addition. High ee, mild conditions for pharma intermediates.
Patent CN111056994B reveals a cost-effective vismodegib synthesis route using Michael addition, offering high purity and scalable manufacturing for global supply chains.
Patent CN110698456A reveals a cost-effective synthesis of 2,3-dihydrothiochromen-4-one using acrylic acid, offering significant supply chain advantages for pharmaceutical intermediate manufacturers.
This patent reveals a base-catalyzed route for benzopyran synthesis offering high yields and mild conditions suitable for scalable pharmaceutical intermediate manufacturing processes globally.
Patent CN110357840B reveals a safe Wittig-based route for 4-furfurylthiopentanone-2, replacing dangerous organometallics with cost-effective chloropropanone for scalable flavor manufacturing.
Patent CN119613463A reveals a copper-catalyzed route for high-purity R-musk ketone, offering significant cost reduction and supply chain reliability for fragrance manufacturers.
Novel chiral squaramide catalyzed route for Ruxolitinib intermediate. High yield, >98% ee. Cost-effective scale-up for pharma supply chains.
Patent CN108147973B details a novel thiourea-catalyzed route for ECPPA, offering superior stereoselectivity and simplified processing for ACE inhibitor manufacturing.